Caitong International Asset Management’s GSK GSK Stock Holding History

Caitong International Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$530K	Buy	+10,104	New	+$534K	0.07%	225
2026 Q1	–	Sell	-283	Closed	-$13.9K	–	2783
2025 Q4	$13.9K	Sell	283 -6,373	-96%	-$297K	﹤0.01%	1079
2025 Q3	$287K	Buy	6,656 +6,654	+332,700%	+$260K	0.2%	51
2025 Q2	$77	Sell	2 -1,479	-100%	-$56.5K	﹤0.01%	1853
2025 Q1	$57.4K	Sell	1,481 -411	-22%	-$15K	0.04%	449
2024 Q4	$64K	Buy	+1,892	New	+$68.1K	0.06%	379

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Caitong International Asset Management's GSK Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in GSK (GSK) in Q2 2026: 10,104 shares worth $530K. The stake represents 0.07% of the portfolio and ranks #225 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in GSK as recently as Q4 2025.

Caitong International Asset Management first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Caitong International Asset Management held 10,104 shares of GSK worth $530K as of Q2 2026.
GSK was a new Caitong International Asset Management position in Q2 2026.
GSK made up 0.07% of Caitong International Asset Management's portfolio in Q2 2026, its #225 holding.
Caitong International Asset Management first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.